Published in EJNMMI Res on June 03, 2013
The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation. Neurobiol Dis (2013) 0.88
White matter disruption at the prodromal stage of Alzheimer's disease: relationships with hippocampal atrophy and episodic memory performance. Neuroimage Clin (2015) 0.83
Early failure of the default-mode network and the pathogenesis of Alzheimer's disease. CNS Neurosci Ther (2014) 0.83
Comparison between PET template-based method and MRI-based method for cortical quantification of florbetapir (AV-45) uptake in vivo. Eur J Nucl Med Mol Imaging (2013) 0.78
Multimodal Magnetic Resonance Imaging in Alzheimer's Disease Patients at Prodromal Stage. J Alzheimers Dis (2016) 0.77
High prevalence of cognitive impairment after intracerebral hemorrhage. PLoS One (2017) 0.75
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage (2002) 49.90
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 21.80
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol (2004) 21.56
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol (2007) 18.62
The FAB: a Frontal Assessment Battery at bedside. Neurology (2000) 8.93
Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol (2010) 8.74
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA (2009) 7.29
Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA (2011) 6.92
Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain (2007) 6.39
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain (2008) 5.89
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol (2013) 5.73
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease. Ann Neurol (2011) 4.38
Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry (1992) 4.16
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study. Lancet Neurol (2012) 3.66
Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Ann Neurol (2010) 3.46
Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB. Neurology (2010) 2.92
Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. Arch Neurol (2011) 2.81
In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18). J Nucl Med (2010) 2.72
Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study. Neurology (2007) 2.61
β-Amyloid burden in healthy aging: regional distribution and cognitive consequences. Neurology (2012) 2.49
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study. Neurology (2012) 2.26
Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease. Ann Neurol (2008) 2.24
CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease. J Neurosci (2010) 2.18
CT and MRI rating of white matter lesions. Cerebrovasc Dis (2002) 1.83
Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging. Alzheimers Dement (2013) 1.77
Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology. Arch Neurol (2011) 1.50
Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease. Neurobiol Aging (2012) 1.49
Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (Aβ) load in Alzheimer's disease dementia. J Neurosci (2012) 1.48
Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals. Neurobiol Aging (2012) 1.43
Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load. J Neurochem (2007) 1.28
Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment. Brain (2011) 1.23
Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent--a pilot study. Nucl Med Biol (2010) 1.16
Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography. J Neurol Neurosurg Psychiatry (2012) 1.12
Evaluation of visual recognition memory in MCI patients. Neurology (2004) 1.11
The French series of autosomal dominant early onset Alzheimer's disease cases: mutation spectrum and cerebrospinal fluid biomarkers. J Alzheimers Dis (2012) 1.03
[Validation of a brief screening scale evaluating praxic abilities for use in memory clinics. Evaluation in 419 controls, 127 mild cognitive impairment and 320 demented patients]. Rev Neurol (Paris) (2009) 0.89
MR, (18)F-FDG, and (18)F-AV45 PET correlate with AD PSEN1 original phenotype. Alzheimer Dis Assoc Disord (2013) 0.80
Amyloid imaging with AV45 ((18)F-florbetapir) in a cognitively normal AβPP duplication carrier. J Alzheimers Dis (2012) 0.79
Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy. Ann Neurol (2007) 3.02
Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum (2007) 2.40
Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen. Arthritis Rheum (2008) 1.99
Investigating acupuncture using brain imaging techniques: the current state of play. Evid Based Complement Alternat Med (2005) 1.59
GFR is better estimated by considering both serum cystatin C and creatinine levels. Pediatr Nephrol (2006) 1.55
Cerebral, facial, and orbital involvement in Erdheim-Chester disease: CT and MR imaging findings. Radiology (2010) 1.53
Correlation between cerebral reorganization and motor recovery after subcortical infarcts. Neuroimage (2003) 1.51
Diagnostic and prognostic value of myocardial perfusion gated SPECT in orthotopic heart transplant recipients. J Nucl Cardiol (2010) 1.41
Sensory alien hand syndrome in corticobasal degeneration: a cerebral blood flow study. Mov Disord (2010) 1.40
Cavernous sinus dural fistulae treated by transvenous approach through the facial vein: report of seven cases and review of the literature. AJNR Am J Neuroradiol (2003) 1.33
Hypothalamic activation in spontaneous migraine attacks. Headache (2007) 1.30
Estimation of glomerular filtration rate in children. Pediatr Nephrol (2002) 1.26
Neural correlates of personally familiar faces: parents, partner and own faces. Hum Brain Mapp (2009) 1.19
Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. Mov Disord (2005) 1.19
Which memory system is impaired first in Alzheimer's disease? J Alzheimers Dis (2011) 1.16
Aging of subcortical nuclei: microstructural, mineralization and atrophy modifications measured in vivo using MRI. Neuroimage (2009) 1.16
Alzheimer's patients engage an alternative network during a memory task. Ann Neurol (2005) 1.13
Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays. Arthritis Res Ther (2006) 1.12
Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen. Arthritis Rheum (2005) 1.09
Validation of a standardized normalization template for statistical parametric mapping analysis of 123I-FP-CIT images. J Nucl Med (2007) 1.07
Limitations of current Parkinson's disease therapy. Ann Neurol (2003) 1.07
Ultra-rapid sensory responses in the human frontal eye field region. J Neurosci (2009) 1.07
Intracranial solitary fibrous tumor: imaging findings. Eur J Radiol (2010) 1.06
Combined volumetry and DTI in subcortical structures of mild cognitive impairment and Alzheimer's disease patients. J Alzheimers Dis (2010) 1.00
Neuropsychology of environmental navigation in humans: review and meta-analysis of FMRI studies in healthy participants. Neuropsychol Rev (2014) 0.99
Photophobia in migraine: an interictal PET study of cortical hyperexcitability and its modulation by pain. J Neurol Neurosurg Psychiatry (2010) 0.98
Brain morphometry reproducibility in multi-center 3T MRI studies: a comparison of cross-sectional and longitudinal segmentations. Neuroimage (2013) 0.97
A multimodal MRI investigation of the subventricular zone in mild cognitive impairment and Alzheimer's disease patients. Neurosci Lett (2009) 0.96
Characterization of white matter fiber bundles with T2* relaxometry and diffusion tensor imaging. Magn Reson Med (2009) 0.96
Optimisation of the OS-EM algorithm and comparison with FBP for image reconstruction on a dual-head camera: a phantom and a clinical 18F-FDG study. Eur J Nucl Med Mol Imaging (2003) 0.94
Clinical and pathophysiological significance of the autoimmune response to citrullinated proteins in rheumatoid arthritis. Joint Bone Spine (2004) 0.93
Parent artery occlusion is not obsolete in giant aneurysms of the ICA. Experience with very-long-term follow-up. Neuroradiology (2010) 0.93
Seeking Huntington disease biomarkers by multimodal, cross-sectional basal ganglia imaging. Hum Brain Mapp (2012) 0.93
High-resolution MR imaging of the cervical arterial wall: what the radiologist needs to know. Radiographics (2009) 0.91
Frontal Assessment Battery is a marker of dorsolateral and medial frontal functions: A SPECT study in frontotemporal dementia. J Neurol Sci (2008) 0.91
Magnetic resonance imaging of pituitary adenomas. Eur Radiol (2004) 0.91
Appropriate use criteria for amyloid PET imaging cannot replace guidelines: on behalf of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging (2013) 0.90
Patterns of semantic memory impairment in Mild Cognitive Impairment. Behav Neurol (2008) 0.90
The connectivity of functional cores reveals different degrees of segregation and integration in the brain at rest. Neuroimage (2012) 0.90
Effects of medial temporal lobe degeneration on brain perfusion in amnestic MCI of AD type: deafferentation and functional compensation? Eur J Nucl Med Mol Imaging (2009) 0.90
Gait and balance disorders in Parkinson's disease: impaired active braking of the fall of centre of gravity. Mov Disord (2009) 0.89
The cognitive and neural expression of semantic memory impairment in mild cognitive impairment and early Alzheimer's disease. Neuropsychologia (2009) 0.89
Clinical phenotype and neuroimaging findings in a French family with hereditary ferritinopathy (FTL498-499InsTC). Mov Disord (2009) 0.89
Where Am I? A new case of developmental topographical disorientation. J Neuropsychol (2013) 0.89
Looking for the compass in a case of developmental topographical disorientation: a behavioral and neuroimaging study. J Clin Exp Neuropsychol (2014) 0.87
Brain responses differ to faces of mothers and fathers. Brain Cogn (2010) 0.87
Multimodal image registration for localization of sentinel nodes in head and neck squamous cell carcinoma. J Oral Maxillofac Surg (2004) 0.87
PET scan perfusion imaging in the Prader-Willi syndrome: new insights into the psychiatric and social disturbances. J Cereb Blood Flow Metab (2010) 0.86
(123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial. J Nucl Med (2013) 0.86
Therapeutic use of CCR5 antagonists is supported by strong expression of CCR5 on CD8(+) T cells in progressive multifocal leukoencephalopathy-associated immune reconstitution inflammatory syndrome. Acta Neuropathol (2015) 0.86
Apomorphine effect on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. Mov Disord (2010) 0.86
Iterative three-dimensional expectation maximization restoration of single photon emission computed tomography images: application in striatal imaging. Med Phys (2006) 0.85
Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer's disease patients. Clin Neurophysiol (2012) 0.85
[Effects of low doses of Li carbonate injected into mice. Functional changes in kidney seem to be related to the oxidative status]. C R Biol (2008) 0.85
Multimodal fMRI tractography in normal subjects and in clinically recovered traumatic brain injury patients. Neuroimage (2007) 0.85
Expression of stress-related genes in a cadmium-resistant A549 human cell line. J Toxicol Environ Health A (2005) 0.84
Neuroprotective and neurotrophic effects of long term lithium treatment in mouse brain. Biometals (2011) 0.84
Hyperactivation of parahippocampal region and fusiform gyrus associated with successful encoding in medial temporal lobe epilepsy. Epilepsia (2011) 0.84
3 Tesla is twice as sensitive as 1.5 Tesla magnetic resonance imaging in the assessment of diffuse axonal injury in traumatic brain injury patients. Funct Neurol (2010) 0.84
The neural dynamics of face detection in the wild revealed by MVPA. J Neurosci (2014) 0.84
Influence of white matter fiber orientation on R2* revealed by MRI segmentation. J Magn Reson Imaging (2012) 0.83
Balloon-assisted embolization of skull base meningioma with liquid embolic agent. J Neurosurg (2010) 0.83
Finding my own way: an fMRI single case study of a subject with developmental topographical disorientation. Neurocase (2014) 0.82
Risks of presurgical embolization of feeding arteries in 137 intracranial meningeal tumors. Acta Neurochir (Wien) (2013) 0.82
KBA.62: a useful marker for primary and metastatic melanomas. Hum Pathol (2008) 0.82
Long-term consolidation of declarative memory: insight from temporal lobe epilepsy. Brain (2011) 0.82
Prognostic value of sympathetic innervation and cardiac asynchrony in dilated cardiomyopathy. Eur J Nucl Med Mol Imaging (2008) 0.82
Apathy as a feature of prodromal Alzheimer's disease: an FDG-PET ADNI study. Int J Geriatr Psychiatry (2014) 0.82
Evidence of bilateral temporal lobe involvement in primary progressive aphasia: a SPECT study. J Nucl Med (2003) 0.82
Correlation between cognitive impairment and cerebral hemodynamic disturbances on perfusion magnetic resonance imaging in European adults with moyamoya disease. Clinical article. J Neurosurg (2010) 0.82
High-level gait and balance disorders in the elderly: a midbrain disease? J Neurol (2013) 0.81
Insight on AV-45 binding in white and grey matter from histogram analysis: a study on early Alzheimer's disease patients and healthy subjects. Eur J Nucl Med Mol Imaging (2014) 0.81
Definite behavioral variant of frontotemporal dementia with C9ORF72 expansions despite positive Alzheimer's disease cerebrospinal fluid biomarkers. J Alzheimers Dis (2012) 0.81
Clinical usefulness of the visibility of the transcerebral veins at 3T on T2*-weighted sequence in acute stroke patients. Eur J Radiol (2011) 0.81
Neuroprotective effects of chronic exposure of SH-SY5Y to low lithium concentration involve glycolysis stimulation, extracellular pyruvate accumulation and resistance to oxidative stress. Int J Neuropsychopharmacol (2012) 0.81
Imaging strategies in pediatric urinary tract infection. Eur Radiol (2005) 0.81
A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives. Eur J Nucl Med Mol Imaging (2015) 0.81
Rhinal-hippocampal interactions during déjà vu. Clin Neurophysiol (2011) 0.80
Effect of subthalamic deep brain stimulation on pain in Parkinson's disease. Pain (2012) 0.80
Supplementary motor area activation is impaired in severe traumatic brain injury parkinsonism. J Neurotrauma (2014) 0.80
Leukocyte SPECT/CT for detecting infection of left-ventricular-assist devices: preliminary results. J Nucl Med (2010) 0.80
Affective decision making under uncertainty during a plausible aviation task: an fMRI study. Neuroimage (2013) 0.80
MR, (18)F-FDG, and (18)F-AV45 PET correlate with AD PSEN1 original phenotype. Alzheimer Dis Assoc Disord (2013) 0.80
Procalcitonin implication in renal cell apoptosis induced by acute pyelonephritis in children. Infect Drug Resist (2008) 0.80
Is a high initial World Federation of Neurosurgery (WFNS) grade really associated with a poor clinical outcome in elderly patients with ruptured intracranial aneurysms treated with coiling? J Neurointerv Surg (2013) 0.80
Functional magnetic resonance imaging in disorders of consciousness: preliminary results of an innovative analysis of brain connectivity. Funct Neurol (2016) 0.80
Nociceptive brain activation in patients with neuropathic pain related to Parkinson's disease. Parkinsonism Relat Disord (2013) 0.79
Amyloid imaging with AV45 ((18)F-florbetapir) in a cognitively normal AβPP duplication carrier. J Alzheimers Dis (2012) 0.79
Preserved auditory cognitive ERPs in severe akinetic mutism: a case report. Brain Res Cogn Brain Res (2004) 0.79